A disapproved ad gets zero clicks, and Google emails you about it. An "Eligible (limited)" ad still runs, serves less often, and shows up nowhere but a status column in your account. In pharmacies, telehealth, supplements and addiction treatment, that second status is where budgets can quietly leak.
All four categories sit under Google's Healthcare and medicines policy, and that policy reads more than your ad. It reads your keywords, your landing page and, when enforcing, your wider site and account. So the teams that win here don't write the boldest ads. Their pages hold up when Google reads them.
This is a field guide: what Google checks, where each category gets tripped up, how to get an ad re-reviewed once you've fixed it, and a checklist to run before launch. One note before we start: this is how we run campaigns, not legal advice. Your regulatory counsel still gets the last word.
Google reviews the whole path, not just the ad
Google checks three things together: the words in your ad, the keywords you bid on and the page the click lands on. The policy also says enforcement can look at your wider website, your account and third-party sources. A clean headline sitting on top of a risky page is still a risky ad.
The result shows up as a policy status on each ad:
Eligible
- What it means
- No restriction applies
- What it costs you
- Nothing
Eligible (limited)
- What it means
- The ad can run, but only in certain locations, in certain contexts, or for certified advertisers
- What it costs you
- Fewer impressions, with no email to tell you
Disapproved
- What it means
- The ad can't serve
- What it costs you
- All of that traffic
| Status | What it means | What it costs you |
|---|---|---|
| Eligible | No restriction applies | Nothing |
| Eligible (limited) | The ad can run, but only in certain locations, in certain contexts, or for certified advertisers | Fewer impressions, with no email to tell you |
| Disapproved | The ad can't serve | All of that traffic |
The middle row is the expensive one, because it's quiet. Google documents that limited ads are restricted in where and when they show. It doesn't document a CPC penalty, and policy status isn't an input to Ad Rank. In our experience the cost still shows up in the numbers, because fewer eligible impressions means you win a different, often pricier, mix of auctions. Treat a CPC drift across every ad pointing at one page as a prompt to check that page's policy status, not as proof of a penalty.
One disambiguation: "Eligible (limited)" also appears at the campaign and keyword level, where it usually means a budget cap, a low bid or a low Quality Score. The policy version we're talking about is the one on the ad itself, with a policy name next to it.
Pharmacies and telehealth: certify first, then bid
If you sell, dispense or prescribe prescription drugs online, Google requires certification before your ads can serve. That covers online pharmacies and telemedicine providers (prescription drug services). Google also applies this cautiously to any landing page that looks like it helps someone get a prescription or buy medicine online. Some certifications need third-party accreditation first, such as LegitScript.
What trips teams up:
- Drug names as keywords. In the US, Canada and New Zealand, you can mention prescription drug terms in ad text and on landing pages without certification. Bidding on them as keywords requires certification (restricted drug terms). Outside those three countries, promotional drug terms aren't allowed in ads or on pages unless you're a certified business such as an online pharmacy or telemedicine provider.
- Location targeting. Prescription drug services are allowed only in a defined list of countries. Target one that isn't on it and Google doesn't allow the promotion there, so the ad is disapproved for that geo.
- Going beyond your certification. A certified domain can still get denied when the site or its terms go past what the certification covers. A telehealth brand certified for one service that adds a page for another is the classic case.
- The rules move. In April 2026, Google opened New Zealand to telemedicine providers that hold LegitScript certification. Online pharmacies in New Zealand still go through the Ministry of Health route. Check the country table before you expand, not after.
The good news is that Google warns you at least 7 days before suspending an account for most of these violations. Two things are different: selling prescription drugs without a prescription, and targeting locations where you aren't licensed. Google treats those as unauthorized pharmacy activity, which is egregious, and those accounts are suspended without warning.
Supplements: one ingredient name can limit the whole account
Supplements don't need certification, so teams assume they're in the clear. Then an ingredient list sinks them. Google's unapproved substances policy prohibits certain products "regardless of any claims of legality." That includes:
- Anything on Google's non-exhaustive list of unapproved pharmaceuticals and supplements
- Products containing ephedra
- hCG marketed for weight loss or weight control, or promoted alongside anabolic steroids
- DHEA, except in campaigns targeting the United States
- Herbal and dietary supplements containing active pharmaceutical or dangerous ingredients
- Products that imply they work as well as a prescription drug or controlled substance
- Products without government approval marketed as safe or effective for preventing, curing or treating a disease
- Products that have been subject to government or regulatory action or warning
- Product names confusingly similar to an unapproved substance or a controlled substance
Several of those are about copy, not chemistry. "Clinically proven to treat anxiety" and "a natural alternative to Xanax" are both claims Google reads as a disease claim or a drug comparison. Google doesn't use the phrase "structure/function"; it prohibits disease claims for unapproved products. The FTC's substantiation rules apply on top of that, so "supports anxiety" still needs evidence behind it.
What works:
- Write benefits, not diagnoses. "Supports energy" and "Supports productivity" describe what the product does. "Treats anxiety" is a disease claim.
- Audit the ingredient copy, not just the hero. Product tables, FAQs and comparison charts all get crawled.
- Build a separate page per angle. An ad group for each angle, a dedicated page, and tightly clustered keywords that support the structure.
Addiction treatment: no certification, no ads
The addiction services category is the strictest of the four. Google restricts all recovery-oriented drug and alcohol services (addiction services). That covers clinical treatment providers, sober living and mutual-help groups, lead generators and referral agencies, and crisis hotlines. To advertise any of them, you need Google's approval, and Google won't give it without the right certification underneath.
What that means in practice:
- Certification comes first. In the US and Canada, providers need LegitScript's addiction treatment certification before Google's own certification.
- Budget for it. LegitScript's published pricing for an organization with one to nine facilities is a $1,595 application fee and $3,095 a year, each charged per facility, with lower per-facility rates above nine facilities. Individual practitioners (one to three practitioners, one website) pay $535 and $1,070. Expedited processing is available, priced separately. LegitScript doesn't publish a timeline, and agencies that run the process describe it as anywhere from a few weeks to a couple of months. Google's own review comes after. Start it well before your launch date.
- Only two countries for private providers. Google lists six locations for addiction services, but in Australia, France, Ireland and New Zealand only government entities may advertise. A private, LegitScript-certified provider can advertise in the United States and Canada only, and each location needs its own application.
- Lead gen and sober homes are in scope, but mostly can't be certified. Comparison sites and "find a rehab near you" funnels fall under the same rules as treatment centers. LegitScript doesn't certify standalone recovery residences without clinical services, and when Google introduced the policy, it named sober homes and referral agencies as businesses that aren't eligible for certification and so can't advertise. In practice, those businesses can't advertise addiction services on Google at all.
Once you're certified, the work is ordinary search work done carefully. Match each keyword theme to a page that speaks to it, whether that's detox, residential, outpatient, insurance or family support, and keep every page within what your certification covers.
The landing page is where most problems live
Ad copy gets reviewed line by line, because everyone knows it's short and public. Landing pages can get less scrutiny, so that's where the problems pile up. Most regulated accounts send every ad group to a few pages: the homepage, a product page, maybe a quiz. Each of those pages has to cover every claim, ingredient and service the brand offers. That's the most risk you can pack onto one URL.
One page per ad group turns that around:
- Smaller surface area. A page for "energy supplement" searches only has to talk about energy. Nothing on it can trip a policy you didn't need to touch.
- Faster fixes. When an ad goes limited, you know exactly which page to check.
- Better ad quality. Google scores every ad on expected CTR, ad relevance and landing page experience, and higher-quality ads typically cost less per click. Quality Score is the 1 to 10 diagnostic that shows you those three factors; Google says it isn't itself an input to the auction. A page that matches its keyword theme moves the factors that are. You'd want that even with no policy in play.
The hard part is building dedicated pages at scale. Most companies have a lengthy design, development, review and legal process, and the pages get stuck in a string of support tickets.
Fixing the page doesn't fix the ad
This is the step most teams miss. Google's own guidance says an ad is re-reviewed when you save an edit to it or appeal; it says nothing about picking up a landing page edit on its own, and in our experience it doesn't. After you fix the page, you have to tell Google, and the appeal rules are specific:
- Appeal from Policy Manager or the Ads page and choose "Made changes to comply with policy." "Dispute decision" is for when you think the original review was wrong.
- If an appeal fails or comes back as a duplicate, make a minor edit to the ad text or final URL and save it. That forces a fresh review.
- Each ad gets a maximum of three appeals. After that, it's a support ticket.
- Wait at least 24 hours between appeals on the same ad or campaign.
- Starting July 21, 2026, decisions more than six months old can't be appealed from inside the account. Older decisions go through support.
Put another way: the fix is page edit, then appeal, then check the status again. Skip the middle step and the limited status can sit there indefinitely.
The pre-launch checklist
Run this before any regulated campaign goes live, and again whenever you add a page or a market.
- Certification is approved for this exact business type, domain and country
- Location targeting is limited to countries the policy allows for your business type
- No prescription drug terms as keywords unless you're certified to bid on them
- No ingredient, product or brand name close to Google's unapproved list, on any part of the page
- No disease, cure or treatment claims for non-approved products
- No comparisons to prescription drugs or controlled substances
- Every ad group lands on a page that matches its keyword theme and nothing broader
- Every page stays within what your certification covers
- Policy status is checked 48 hours after launch, and ad-level "Eligible (limited)" is treated as a bug to fix
- Every page fix is followed by an appeal marked "Made changes to comply," and the status is checked again after
- CPC is watched by landing page, so a page-level problem shows up as a pattern
Every ad group gets a page. Every page gets checked.
This is the problem Flint is built for. Flint builds an on-brand landing page for each ad group, matched to its keywords, so a supplement search lands on a supplement page and a detox search lands on a detox page. Your brand and compliance teams review a short, specific page instead of a homepage that tries to say everything.
The Flint Google Ads agent monitors the account around the clock: it flags ads that drop to limited, points at the page behind them, and tracks CPC by landing page. When a problem is found, the fix can be a page edit and an appeal, not a rebuild.
Regulated categories will always have more rules than the rest of search. With one page per ad group, those rules apply to each page separately instead of to your whole account.
Talk to sales to see how Flint runs regulated health campaigns.
Sources
- Healthcare and medicines policy
- Prescription drug services
- Restricted drug terms
- Unapproved substances
- Unapproved pharmaceuticals and supplements list
- Addiction services
- Healthcare: Addiction services (April 2018 policy announcement)
- Healthcare and medicines policy update, April 2026
- Fix a disapproved ad or appeal a policy decision
- Eligible (limited): Definition
- About Quality Score
- About ad quality
- LegitScript addiction treatment certification fact sheet

